Treatment Parameters and Outcome in 680 Treatments of Internal Radiation With Resin 90Y-Microspheres for Unresectable Hepatic Tumors

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1494-1500

  Kennedy, Andrew S ^a   McNeillie, Patrick ^b   Dezarn, William A ^a   Nutting, Charles ^c   Sangro, Bruno ^d   Wertman, Dan ^e   Garafalo, Michael ^f   Liu, David ^g   Coldwell, Douglas ^h   Savin, Michael ⁱ   Jakobs, Tobias ^j   Rose, Steven ^k   Warner, Richard ^l   Carter, Dennis ^c   Sapareto, Stephen ^m   Nag, Subir ⁿ   Gulec, Seza ^o   Calkins, Allison ^p   Gates, Vanessa L ^q   Salem, Riad ^q  

^a Wake Radiology Oncology   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Sky Ridge Medical Center   (United States)

^d UNIVERSITY OF NAVARRA   (Spain)

^e Durham Regional Hospital   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g St Vincent's Hospital   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ WILLIAM BEAUMONT HOSPITAL   (United States)

^j UNIVERSITY OF MUNICH   (Germany)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l MOUNT SINAI MEDICAL CENTER   (United States)

^m BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

ⁿ THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^o Goshen Medical Center   (United States)

^p ST JOSEPH HOSPITAL   (United States)

^q Northwestern Medical Center   (United States)

more..

Author keywords

90Y; Dosimetry; Liver; Microsphere; Radioembolization; Selective Internal Radiation Therapy

Indexed keywords

90Y; ADVERSE EVENTS; HEPATIC TUMORS; INTERNAL RADIATION; LIVER TOXICITY; MEDICAL CENTER; MULTIFACTORIAL ANALYSIS; NATIONAL CANCER INSTITUTE; PREDICTIVE MODELS; RADIATION PARAMETERS; RADIATION-INDUCED LIVER DISEASE; RADIOEMBOLIZATION; SELECTIVE INTERNAL RADIATION THERAPY; TREATMENT PARAMETERS;

DOSIMETERS; DOSIMETRY; LIVER; MICROSPHERES; PREDICTIVE CONTROL SYSTEMS; RADIOTHERAPY; RESINS; TOXICITY; TUMORS;

RADIATION;

MICROSPHERE; RESIN; YTTRIUM 90;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RADIATION SICKNESS; RADIOACTIVITY; TREATMENT OUTCOME; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICROSPHERES; MODELS, CHEMICAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 67749094844     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.005     Document Type: Article

References (57)

1. World Health Organization. Cancer Fact Sheets. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html. Accessed December 8, 2008.
2. Ariel I.M. Radioactive isotopes for adjuvant cancer therapy. Arch Surg 89 (1964) 244-249
3. Breedis C., and Young G. The blood supply of neoplasms in the liver. Am J Pathol 30 (1954) 969-984
4. Gray B., Van Hazel G., Hope M., et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 (2001) 1711-1720
5. 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: Modern USA experience. Int J Radiat Oncol Biol Phys 65 (2006) 412-425
6. Salem R., and Thurston K.G. Radioembolization with yttrium-90 microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 3: Comprehensive literature review and future direction. J Vasc Interv Radiol 17 (2006) 1571-1593
7. 90Y microspheres-Safety, efficacy, and survival. Radiology 247 (2008) 507-515
8. Sharma R.A., Van Hazel G.A., Morgan B., et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25 (2007) 1099-1106
9. 90Y microspheres for colorectal liver metastases: Single-centre experience with 100 patients. ANZ J Surg 76 (2006) 696-703
10. Geschwind J.F., Salem R., Carr B.I., et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127 Suppl. (2004) S194-S205
11. 90yttrium microspheres. Int J Radiat Oncol Biol Phys 40 (1998) 583-592
12. 90Y-microspheres: Early results in 148 patients. Am J Clin Oncol 31 (2008) 271-279
13. King J., Quinn R., Glenn D.M., et al. Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases. Cancer 113 (2008) 921-929
14. 90Y Radioembolization for metastatic neuroendocrine liver tumors: Preliminary results from a multi-institutional experience. Ann Surg 247 (2008) 1029-1035
15. 90Y Radioembolization of metastatic breast cancer to the liver: Toxicity, imaging response, survival. J Vasc Interv Radiol 18 (2007) 621-628
16. Coldwell D.M., Kennedy A.S., and Nutting C.W. Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69 (2007) 800-804
17. Jakobs T.F., Hoffmann R.T., Fischer T., et al. Radioembolization in patients with hepatic metastases from breast cancer. J Vasc Interv Radiol 19 (2008) 683-690
18. Kennedy A.S., Murthy R., Sarfaraz M., et al. Outpatient hepatic artery brachytherapy for primary and secondary hepatic malignancies. [Abstract]. Radiology 221P (2001) 468
19. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
20. Fajardo L.F., Berthrong M., and Liver A.RE. Radiation pathology. 1st ed. (2001), Oxford University, New York pp. 249-257
21. Reed G., and Cox A. The human liver after radiation injury. Am J Pathol 48 (1966) 597-612
22. 90Y microspheres: Angiographic and technical considerations. Cardiovasc Intervent Radiol 30 (2007) 571-592
23. Murthy R., Nunez R., Szklaruk J., et al. Yttrium-90 microsphere therapy for hepatic malignancy: Devices, indications, technical considerations, and potential complications. Radiographics 25 Suppl. 1 (2005) S41-S55
24. Kennedy A., Nag S., Salem R., et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium. Int J Radiat Oncol Biol Phys 68 (2007) 13-23
25. 90Y microspheres (TheraSphere): Safety, tumor response, and survival. J Vasc Interv Radiol 16 (2005) 1627-1639
26. 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: Special topics. J Vasc Interv Radiol 17 (2006) 1425-1439
27. 90yttrium microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17 (2006) 1251-1278
28. 90Y microspheres in man: Review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60 (2004) 1552-1563
29. Ho S., Lau W.Y., Leung T.W., et al. Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24 (1997) 293-298
30. Ho S., Lau W.Y., Leung T.W., et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 23 (1996) 947-952
31. Sarfaraz M., Kennedy A.S., Cao Z.J., et al. Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors. Med Phys 30 (2003) 199-203
32. Sarfaraz M., Kennedy A.S., Cao Z.J., et al. Radiation dose distribution in patients treated with Y-90 microspheres for non-resectable hepatic tumors. Int J Radiat Biol Phys 51 (2001) 32-33
33. Sarfaraz M., Kennedy A.S., Lodge M.A., et al. Radiation absorbed dose distribution in a patient treated with yttrium-90 microspheres for hepatocellular carcinoma. Med Phys 31 (2004) 2449-2453
34. Ingold J., Reed G., and Kaplan H. Radiation hepatitis. AJR Am J Roentgenol 93 (1965) 200-208
35. Fajardo L.F., and Colby T.V. Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104 (1980) 584-588
36. Lawrence T.S., Ten Haken R.K., Kessler M.L., et al. The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23 (1992) 781-788
37. Lawrence T.S., and Tesser R.J. Ten Haken RK. An application of dose volume histograms to the treatment of intrahepatic malignancies with radiation therapy. Int J Radiat Oncol Biol Phys 19 (1990) 1041-1047
38. Therasse P., Eisenhauer E.A., and Verweij J. RECIST revisited: A review of validation studies on tumour assessment. Eur J Cancer 42 (2006) 1031-1039
39. Lawrence T.S., Davis M.A., Maybaum J., et al. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer. Cancer Res 52 (1992) 3698-3704
40. Lawrence T.S., Dworzanin L.M., Walker-Andrews S.C., et al. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine. Int J Radiat Oncol Biol Phys 20 (1991) 555-561
41. Lawrence T.S., Kessler M.L., and Robertson J.M. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer. Oncology (Huntingt) 7 (1993) 51-57 discussion, 57-58, 63
42. Dawson L.A., Brock K.K., Kazanjian S., et al. The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51 (2001) 1410-1421
43. Dawson L.A., McGinn C.J., Normolle D., et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18 (2000) 2210-2218
44. Dawson L.A. Ten Haken RK. Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15 (2005) 279-283
45. Dawson L.A., Ten Haken R.K., and Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 11 (2001) 240-246
46. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31 (1995) 883-891
47. McGinn C.J., Ten Haken R.K., Ensminger W.D., et al. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 16 (1998) 2246-2252
48. Ten Haken R.K., Lawrence T.S., McShan D.L., et al. Technical considerations in the use of 3-D beam arrangements in the abdomen. Radiother Oncol 22 (1991) 19-28
49. Ten Haken R.K., Martel M.K., Kessler M.L., et al. Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 27 (1993) 689-695
50. Yorke E.D., Jackson A., Fox R.A., et al. Can current models explain the lack of liver complications in Y-90 microsphere therapy?. Clin Cancer Res 5 Suppl. (1999) 3024S-3030S
51. Goin J.E., Salem R., Carr B.I., et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities. J Vasc Interv Radiol 16 (2005) 205-213
52. Goin J.E., Salem R., Carr B.I., et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: A risk-stratification analysis. J Vasc Interv Radiol 16 (2005) 195-203
53. Toohey R.E., Stabin M.G., and Watson E.E. The AAPM/RSNA physics tutorial for residents: Internal radiation dosimetry: Principles and applications. Radiographics 20 (2000) 533-546 quiz, 531-532
54. ®): Assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol 29 (2006) 522-529
55. 90Y-microspheres. J Nucl Med 41 (2000) 1673-1681
56. Sangro B., Gil-Alzugaray B., Rodriguez J., et al. Liver disease induced by radioembolization of liver tumors: Description and possible risk factors. Cancer 112 (2008) 1538-1546
57. Gulec S.A., Mesoloras G., Dezarn W.A., et al. Safety and efficacy evaluation of y-90 microsphere treatment using Medical Internal Radiation Dosimetry (MIRD) in patients with liver malignancies. [Abstract]. J Nucl Med 47 (2006) 493P